FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081038863> ?p ?o ?g. }

• W3081038863 endingPage "e0008489" @default.
• W3081038863 startingPage "e0008489" @default.
• W3081038863 abstract "Piroplasmosis treatment has been based on the use of imidocarb dipropionate or diminazene aceturate (DA), however, their toxic effects. Therefore, the discovery of new drug molecules and targets is urgently needed. Cryptolepine (CRY) is a pharmacologically active plant alkaloid; it has significant potential as an antiprotozoal and antibacterial under different in vitro and in vivo conditions. The fluorescence assay was used for evaluating the inhibitory effect of CRY on four Babesia species and Theileria equi in vitro, and on the multiplication of B. microti in mice. The toxicity assay was evaluated on Madin-Darby bovine kidney (MDBK), mouse embryonic fibroblast (NIH/3T3), and human foreskin fibroblast (HFF) cell lines. The half-maximal inhibitory concentration (IC50) values of CRY on Babesia bovis, B. bigemina, B. divergens, B. caballi, and T. equi were 1740 ± 0.377, 1400 ± 0.6, 790 ± 0.32, 600 ± 0.53, and 730 ± 0.025 nM, respectively. The toxicity assay on MDBK, NIH/3T3, and HFF cell lines showed that CRY affected the viability of cells with a half-maximum effective concentration (EC50) of 86.67 ± 4.43, 95.29 ± 2.7, and higher than 100 μM, respectively. In mice experiments, CRY at a concentration of 5 mg/kg effectively inhibited the growth of B. microti, while CRY-atovaquone (AQ) and CRY-DA combinations showed higher chemotherapeutic effects than CRY alone. Our results showed that CRY has the potential to be an alternative remedy for treating piroplasmosis." @default.
• W3081038863 created "2020-09-01" @default.
• W3081038863 creator A5043216135 @default.
• W3081038863 creator A5047364318 @default.
• W3081038863 creator A5060667919 @default.
• W3081038863 creator A5064062758 @default.
• W3081038863 creator A5080950945 @default.
• W3081038863 creator A5090528770 @default.
• W3081038863 date "2020-08-27" @default.
• W3081038863 modified "2023-09-30" @default.
• W3081038863 title "In vitro and in vivo growth inhibitory activities of cryptolepine hydrate against several Babesia species and Theileria equi" @default.
• W3081038863 cites W1971339883 @default.
• W3081038863 cites W1983672823 @default.
• W3081038863 cites W1994936315 @default.
• W3081038863 cites W2007524354 @default.
• W3081038863 cites W2025912997 @default.
• W3081038863 cites W2026641599 @default.
• W3081038863 cites W2036330755 @default.
• W3081038863 cites W2037386120 @default.
• W3081038863 cites W2040554029 @default.
• W3081038863 cites W2043309355 @default.
• W3081038863 cites W2058590672 @default.
• W3081038863 cites W2064420872 @default.
• W3081038863 cites W2084614792 @default.
• W3081038863 cites W2101458391 @default.
• W3081038863 cites W2103562758 @default.
• W3081038863 cites W2108815635 @default.
• W3081038863 cites W2152185415 @default.
• W3081038863 cites W2153708797 @default.
• W3081038863 cites W2165143921 @default.
• W3081038863 cites W2285568030 @default.
• W3081038863 cites W2418838928 @default.
• W3081038863 cites W2562289765 @default.
• W3081038863 cites W2781409303 @default.
• W3081038863 cites W2804147555 @default.
• W3081038863 cites W2941392096 @default.
• W3081038863 cites W2947030135 @default.
• W3081038863 cites W2949558787 @default.
• W3081038863 cites W2959708344 @default.
• W3081038863 cites W2977468800 @default.
• W3081038863 cites W3002282316 @default.
• W3081038863 cites W3005703408 @default.
• W3081038863 cites W3005761987 @default.
• W3081038863 cites W3006799850 @default.
• W3081038863 cites W3015814524 @default.
• W3081038863 doi "https://doi.org/10.1371/journal.pntd.0008489" @default.
• W3081038863 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7451656" @default.
• W3081038863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32853247" @default.
• W3081038863 hasPublicationYear "2020" @default.
• W3081038863 type Work @default.
• W3081038863 sameAs 3081038863 @default.
• W3081038863 citedByCount "11" @default.
• W3081038863 countsByYear W30810388632021 @default.
• W3081038863 countsByYear W30810388632022 @default.
• W3081038863 countsByYear W30810388632023 @default.
• W3081038863 crossrefType "journal-article" @default.
• W3081038863 hasAuthorship W3081038863A5043216135 @default.
• W3081038863 hasAuthorship W3081038863A5047364318 @default.
• W3081038863 hasAuthorship W3081038863A5060667919 @default.
• W3081038863 hasAuthorship W3081038863A5064062758 @default.
• W3081038863 hasAuthorship W3081038863A5080950945 @default.
• W3081038863 hasAuthorship W3081038863A5090528770 @default.
• W3081038863 hasBestOaLocation W30810388631 @default.
• W3081038863 hasConcept C136764020 @default.
• W3081038863 hasConcept C150903083 @default.
• W3081038863 hasConcept C153911025 @default.
• W3081038863 hasConcept C159047783 @default.
• W3081038863 hasConcept C178790620 @default.
• W3081038863 hasConcept C185592680 @default.
• W3081038863 hasConcept C202751555 @default.
• W3081038863 hasConcept C207001950 @default.
• W3081038863 hasConcept C2776111823 @default.
• W3081038863 hasConcept C2777119855 @default.
• W3081038863 hasConcept C2777752497 @default.
• W3081038863 hasConcept C2780581805 @default.
• W3081038863 hasConcept C2910449918 @default.
• W3081038863 hasConcept C29730261 @default.
• W3081038863 hasConcept C41008148 @default.
• W3081038863 hasConcept C55493867 @default.
• W3081038863 hasConcept C71928629 @default.
• W3081038863 hasConcept C86803240 @default.
• W3081038863 hasConcept C96529984 @default.
• W3081038863 hasConcept C98274493 @default.
• W3081038863 hasConceptScore W3081038863C136764020 @default.
• W3081038863 hasConceptScore W3081038863C150903083 @default.
• W3081038863 hasConceptScore W3081038863C153911025 @default.
• W3081038863 hasConceptScore W3081038863C159047783 @default.
• W3081038863 hasConceptScore W3081038863C178790620 @default.
• W3081038863 hasConceptScore W3081038863C185592680 @default.
• W3081038863 hasConceptScore W3081038863C202751555 @default.
• W3081038863 hasConceptScore W3081038863C207001950 @default.
• W3081038863 hasConceptScore W3081038863C2776111823 @default.
• W3081038863 hasConceptScore W3081038863C2777119855 @default.
• W3081038863 hasConceptScore W3081038863C2777752497 @default.
• W3081038863 hasConceptScore W3081038863C2780581805 @default.
• W3081038863 hasConceptScore W3081038863C2910449918 @default.
• W3081038863 hasConceptScore W3081038863C29730261 @default.
• W3081038863 hasConceptScore W3081038863C41008148 @default.

• next